Mitchell Scott

Mitchell Scott is an experienced professional with a strong background in law enforcement and organizational management. Currently serving as the Senior Director of the Special Investigations Unit and Audit at Prime Therapeutics since March 2019, Mitchell is responsible for mitigating organizational risk related to regulatory compliance and client obligations while addressing fraud, waste, and abuse in healthcare. Prior experience includes roles as Director of the Special Investigations Unit and Pharmacy Audit, and leadership positions at the National Association of Drug Diversion Investigators and various capacities within the Rosemount and Apple Valley Police Departments. Educational qualifications include a Master's Degree in Organizational Management from Concordia University-St. Paul and a BS in Management with a focus on Justice Administration from Kaplan University.